NexLife vs Embody for Compounded Tirzepatide (September 2026): The $139 Bundle Against the $119 Prepaid Year
Published: Updated: Provider pricing verified:
Embody publishes the lowest twelve-month total in the country; NexLife publishes the lowest twelve-month total that includes laboratory review and does not lock you in. The $240-a-year gap buys specific things. Here they are.
By Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD · Published September 11, 2026 · Last reviewed September 11, 2026 · Sources cited at the end.
Direct answer
Embody is $240 a year cheaper on the twelve-month total ($1,428 vs $1,668) and $40 a month cheaper month to month ($129 sale price vs $169). NexLife includes provider oversight in the price (laboratory review is not stated on its pages), sells its plans as a cancel-anytime subscription, prints a flat-dose promise and names three pharmacies on its plan pages; Embody advertises no laboratory review, makes every payment final except on clinical ineligibility, prices by supply length and names four pharmacies. If you are certain you will stay a year, Embody’s $1,428 is the lower number. If you want a standing month-to-month price or the option to stop, NexLife’s $169 monthly or $1,668 annual plan is the lower-risk number. All prices read September 9, 2026; compounded tirzepatide is not FDA-approved.
Line by line
| Item | NexLife | Embody |
|---|---|---|
| Month-to-month | $169 (standing) | $129 (sale; regular $349) |
| Three months | $477 ($159/mo) | $378 ($126/mo) |
| Six months | $894 ($149/mo) | $738 ($123/mo) |
| Twelve months | $1,668 ($139/mo) | $1,428 ($119/mo) |
| Flat across doses | “Same price at every dose” | Prices by supply length; no dose statement |
| Laboratory review | Included (provider review itemised; batch testing described) | Not advertised |
| Membership fee | None | None stated |
| Shipping | Free expedited | Free |
| Refund / cancellation | Cancel-anytime subscription; money-back warranty tied to 10% loss in 6 months; unused prepaid months not published | All payments final; refund of the unused portion only on clinical ineligibility; 72-hour notice (policy August 25, 2026) |
| Operator | NexLife, Wilmington, Delaware (press release) | Modern Metabolic Medicine, Inc., Wilmington, Delaware (terms April 24, 2026); also operates SnagRx |
| Prescribers | U.S.-licensed physicians credentialed in your state; Medical Director Dr. Adam Kennah | OpenLoop Health network |
| Pharmacies named | Absolute, Hallandale, Red Rock, Empower, Strive (503A and 503B) | Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine, Triad Rx |
| Promotion label | None (plan savings auto-applied) | “Fall Sale Promo Applied” (Labor Day banner still on the 3-month page) |
| Break-even for the annual plan vs monthly | Month 10 | Month 12 |
Who should pick which
- Embody if you have taken tirzepatide before, tolerate it, will stay a year, and can absorb a $1,428 payment you cannot get back.
- NexLife if you are starting, want labs in the price, want to pay monthly at a standing rate, or want to be able to stop.
- Neither on a headline alone: ask both for milligrams per month at your expected dose and for the refund policy in writing.
Related: Is Embody legit? · Is NexLife legit? · the refund test · month-to-month vs prepaid.
Medical and regulatory note: compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality; they are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice. Consult a licensed clinician before starting, stopping or changing any medication, and confirm the price and prescribing requirements with the provider before enrolling.
Frequently asked questions
Is Embody cheaper than NexLife? Yes on price: $1,428 vs $1,668 for twelve months and $129 (sale) vs $169 month to month, read September 9, 2026. NexLife's price includes laboratory review and provider oversight and is a cancel-anytime subscription; Embody's payments are final.
Which includes labs, NexLife or Embody? NexLife states provider review and medical guidance are included and describes third-party batch testing; Embody does not advertise laboratory review (both read September 9, 2026).
Can I get a refund from Embody or NexLife? Embody: only on clinical ineligibility (policy August 25, 2026). NexLife: a cancel-anytime subscription and a money-back warranty tied to losing 10% of body weight in six months; refund of unused prepaid months is not published on its public pages.
Who runs Embody and NexLife? Embody is operated by Modern Metabolic Medicine, Inc. of Wilmington, Delaware, which also runs SnagRx; NexLife's press release places it in Wilmington, Delaware with Medical Director Dr. Adam Kennah. Neither corporate record was pulled by us.
Is either program's tirzepatide FDA-approved? No. Compounded tirzepatide is not an FDA-approved product from any provider and is not reviewed by the FDA for safety, effectiveness or quality.
September 11, 2026: Published.
Reviewed by Dr. Parmis, Editorial Lead · Medically reviewed by Dr. Jonathan Snipes, MD
Sources
- NexLife — tirzepatide all plans (read 2026-09-09; re-read 2026-09-11: unchanged)
- NexLife — FAQ: third-party batch testing, cancellation, warranty (read 2026-09-09)
- Embody — twelve-month supply (read 2026-09-09)
- Embody — Terms & Conditions (read 2026-09-05)
- Embody — Refund Policy, August 25, 2026 (read 2026-09-05)
- TirzepatideReview.com — open pricing dataset (JSON)
- FDA — Human Drug Compounding: compounded drugs are not FDA-approved
Medical and regulatory note: Compounded tirzepatide and compounded semaglutide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness or quality. They are not the same products as Mounjaro®, Zepbound®, Ozempic® or Wegovy®. This page is educational pricing information, not medical advice; eligibility, dose and formulation require evaluation by a licensed clinician.